Jalyn

Product manufactured by Glaxosmithkline Llc

Application Nr Approved Date Route Status External Links
NDA022460 2010-06-14 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Jalyn Is A Combination Of Dutasteride, A 5-Alpha-Reductase Inhibitor, And Tamsulosin, An Alpha-Adrenergic Antagonist, Indicated For The Treatment Of Symptomatic Benign Prostatic Hyperplasia (bph) In Men With An Enlarged Prostate. (1.1) Limitations Of Use: Dutasteride-Containing Products, Including Jalyn, Are Not Approved For The Prevention Of Prostate Cancer. (1.2) 1.1 Benign Prostatic Hyperplasia (bph) Treatment Jalyn (dutasteride And Tamsulosin Hydrochloride) Capsules Are Indicated For The Treatment Of Symptomatic Bph In Men With An Enlarged Prostate. 1.2 Limitations Of Use Dutasteride-Containing Products, Including Jalyn, Are Not Approved For The Prevention Of Prostate Cancer.

All Formulated Excipients (1 Total)

Name Structure Kind Function Status
1. Glycerin GLYCERIN Molecular MISC-Miscellaneous FS-Substances permitted as optional ingredient in a standardized food.

Active Ingredients ( 2 Total)

Comments